Canaccord Genuity Maintains Buy on Core Scientific, Raises Price Target to $17
Portfolio Pulse from Benzinga Newsdesk
Canaccord Genuity has maintained its Buy rating on Core Scientific (NASDAQ:CORZ) and raised the price target from $16 to $17, indicating a positive outlook for the company's stock.
October 23, 2024 | 10:39 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Canaccord Genuity has reaffirmed its Buy rating for Core Scientific and increased the price target from $16 to $17, suggesting confidence in the company's future performance.
The increase in the price target from $16 to $17 by Canaccord Genuity, along with the maintained Buy rating, indicates a positive sentiment from analysts towards Core Scientific. This is likely to boost investor confidence and potentially lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100